{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T21:21:18Z","timestamp":1773523278185,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"DOI":"10.7759\/cureus.101938","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:01:41Z","timestamp":1768960901000},"source":"Crossref","is-referenced-by-count":1,"title":["Cefazolin: A Rare Etiology of Induced Coagulopathy"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anam","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cayleigh","family":"Blumrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03106.x","article-title":"Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status","volume":"28","author":"Shearer MJ","year":"1988","unstructured":"Shearer MJ, Bechtold H, Andrassy K, et al.. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol. 1988, 28:88-95. 10.1002\/j.1552-4604.1988.tb03106.x","journal-title":"J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070243","article-title":"Cefazolin-induced hypoprothrombinemia","volume":"65","author":"Chung AH","year":"2008","unstructured":"Chung AH, Watson K. Cefazolin-induced hypoprothrombinemia. Am J Health Syst Pharm. 2008, 65:823-6. 10.2146\/ajhp070243","journal-title":"Am J Health Syst Pharm"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/idr13010021","article-title":"Deranged coagulation profile secondary to cefazolin use: case report","volume":"13","author":"Ngiam JN","year":"2021","unstructured":"Ngiam JN, Liong TS, Tham SM, et al.. Deranged coagulation profile secondary to cefazolin use: case report. Infect Dis Rep. 2021, 13:187-90. 10.3390\/idr13010021","journal-title":"Infect Dis Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5194\/jbji-6-131-2021","article-title":"Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous","volume":"6","author":"Kouki I","year":"2021","unstructured":"Kouki I, Montagner C, Mauhin W, et al.. Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous. J Bone Jt Infect. 2021, 6:131-4. 10.5194\/jbji-6-131-2021","journal-title":"J Bone Jt Infect"},{"key":"ref5","article-title":"Antimicrobial prophylaxis in minor and major surgery","volume":"81","author":"Bassetti M","year":"2015","unstructured":"Bassetti M, Righi E, Astilean A, Corcione S, Petrolo A, Farina EC, De Rosa FG. Antimicrobial prophylaxis in minor and major surgery. Minerva Anestesiol. 2015, 81:76-91.","journal-title":"Minerva Anestesiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel JS","year":"2017","unstructured":"McDanel JS, Roghmann MC, Perencevich EN, et al.. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017, 65:100-6. 10.1093\/cid\/cix287","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3412-6","article-title":"Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin","volume":"38","author":"Strazzulla A","year":"2019","unstructured":"Strazzulla A, Chakvetadze C, Picque M, et al.. Evolution of haemostatic parameters and risk of bleeding during treatment with cefazolin. Eur J Clin Microbiol Infect Dis. 2019, 38:177-83. 10.1007\/s10096-018-3412-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2017.07.006","article-title":"Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis","volume":"37","author":"Angles E","year":"2018","unstructured":"Angles E, Mouton C, Perino J, Remy A, Ouattara A. Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis. Anaesth Crit Care Pain Med. 2018, 37:167-70. 10.1016\/j.accpm.2017.07.006","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014537038","article-title":"Necrotizing esophagitis and bleeding associated with cefazolin","volume":"48","author":"Barnes T","year":"2014","unstructured":"Barnes T, Yan S, Kaakeh Y. Necrotizing esophagitis and bleeding associated with cefazolin. Ann Pharmacother. 2014, 48:1214-8. 10.1177\/1060028014537038","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455472-cefazolin-a-rare-etiology-of-induced-coagulopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T02:01:42Z","timestamp":1768960902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455472-cefazolin-a-rare-etiology-of-induced-coagulopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.101938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}